Parthenon LLC Sells 5,975 Shares of Walgreens Boots Alliance Inc (WBA)

Parthenon LLC lowered its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 6.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,794 shares of the pharmacy operator’s stock after selling 5,975 shares during the period. Walgreens Boots Alliance comprises 1.6% of Parthenon LLC’s portfolio, making the stock its 19th largest holding. Parthenon LLC’s holdings in Walgreens Boots Alliance were worth $6,857,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Hudock Capital Group LLC boosted its stake in Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 6 shares in the last quarter. Westside Investment Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 10.4% in the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 125 shares in the last quarter. IHT Wealth Management LLC boosted its stake in shares of Walgreens Boots Alliance by 46.3% in the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after purchasing an additional 2,199 shares in the last quarter. Bristlecone Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance in the 3rd quarter valued at $135,000. Finally, Private Vista LLC boosted its stake in shares of Walgreens Boots Alliance by 6,403.7% in the 2nd quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock valued at $140,000 after purchasing an additional 574,218 shares in the last quarter. Hedge funds and other institutional investors own 61.41% of the company’s stock.

WBA has been the topic of several recent analyst reports. Pivotal Research reduced their target price on shares of Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating on the stock in a research note on Tuesday, October 24th. Loop Capital initiated coverage on shares of Walgreens Boots Alliance in a research note on Thursday, August 24th. They issued a “buy” rating and a $95.00 target price on the stock. Needham & Company LLC restated a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, October 12th. Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance in a research note on Monday, December 4th. They issued a “hold” rating and a $78.00 target price on the stock. Finally, BidaskClub downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $86.47.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director John Anthony Lederer acquired 20,000 shares of the company’s stock in a transaction on Thursday, October 26th. The shares were purchased at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. Insiders own 14.80% of the company’s stock.

Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $71.94 on Friday. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance Inc has a twelve month low of $63.82 and a twelve month high of $88.00. The stock has a market capitalization of $72,850.00, a PE ratio of 13.80, a P/E/G ratio of 1.25 and a beta of 1.22.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business had revenue of $30.15 billion during the quarter, compared to analysts’ expectations of $29.93 billion. During the same period in the previous year, the business posted $1.07 earnings per share. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. research analysts predict that Walgreens Boots Alliance Inc will post 5.54 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were issued a dividend of $0.40 per share. The ex-dividend date was Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.22%. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.

Walgreens Boots Alliance announced that its Board of Directors has authorized a stock buyback program on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s management believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: This report was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another publication, it was illegally stolen and republished in violation of US and international trademark & copyright law. The original version of this report can be accessed at https://sportsperspectives.com/2017/12/17/parthenon-llc-sells-5975-shares-of-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply